Stainless formulation vessels and a jacketed reactor in a dim pilot suite

How We Work: Turning Actives into Products

Vegalab adds delivery, validation, brand and market access to an active you already make. The manufacturer keeps production of the raw material; we build the encapsulated format, organize the evidence and carry it to market under arrangements tailored case by case. The result is a finished, defensible product rather than a commodity ingredient competing on price per kilo.

Four things we add

Nano-delivery: our patent-pending encapsulation targets absorption, stability and on-target release. Independent validation: more than 30 research, testing and evaluation relationships let us run stability, dissolution, permeability and human studies efficiently. Swiss brand and Western regulatory standing: a credible biotech name, registered marks, support for regulatory routes such as new dietary ingredient notifications, GRAS-style dossiers and Canadian NHP licenses, and third-party certificates of analysis. Route to market: North American and international distribution, a USD-invoicing storefront and the ability to build a finished consumer brand.

Who we partner with

Raw material and API manufacturers who want a higher-value finished form of their molecule. Nutraceutical and longevity ingredient producers facing crowded markets for NMN, NAC, glutathione, CoQ10 or curcumin. Cosmetic active suppliers moving into professional or ingestible formats. Clinics and distributors seeking differentiated products with documented delivery data. Every partner screen starts by confirming a lawful pathway in the target market, before any laboratory work begins.

How an engagement runs

It starts with a technical screen of the active: molecular weight, logP, solubility, degradation route, current route of administration and regulatory status in each target market. A paid feasibility study follows, covering encapsulation efficiency, particle size, stability under ICH conditions and release in simulated gastric and intestinal fluids. If the data support it, we move to scale-up, clinical or consumer validation and a commercial agreement. Ownership is collaborative and co-owned rather than a simple supply contract, with terms set per project.

Diagram of linked circles showing a raw active moving through encapsulation, validation and market access stages — The partner keeps raw material production; Vegalab adds the encapsulated format, the evidence file and the route to market.

What partners should expect

Clear go and no-go calls. Each active gets the delivery approach its barrier calls for, and oral peptides run through a dedicated program. Every result is reported against the unencapsulated control. Timelines depend on the regulatory route: a cosmetic or supplement format can move in months, while anything that makes a drug claim requires a drug development program.

Key facts

Oral semaglutide required co-formulation with 300 mg SNAC to reach roughly 1% bioavailability, showing how much delivery work sits between a molecule and a product (Buckley et al. 2018, Sci Transl Med)
A new dietary ingredient must be notified to FDA at least 75 days before marketing unless it was present in the food supply unaltered (21 U.S.C. 350b)
Stability claims for new formulations are normally supported by long-term and accelerated testing under ICH conditions (ICH Q1A(R2) 2003)
Canadian natural health products require a product license and NPN from Health Canada before sale (Natural Health Products Regulations, SOR/2003-196)

How our delivery technology applies

For an ingredient owner, encapsulation is how a commodity becomes a specification. Programmable layers let us set dissolution, stability and release targets that can be written into a product specification and tested batch to batch. That creates a documented difference, such as oxidation retained after six months or release delayed past the stomach, which a partner can defend commercially and a regulator can review, rather than an unsupported absorption claim on a label.

Send us your active and target market for a technical screen.